AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 292: E1280-E1287, 2007. First published January 9, 2007; doi:10.1152/ajpendo.00277.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/E1280    most recent
00277.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, H.
Right arrow Articles by Cassis, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, H.
Right arrow Articles by Cassis, L. A.

Angiotensin II increases adipose angiotensinogen expression

Hong Lu,1 Carine M. Boustany-Kari,2 Alan Daugherty,1,2 and Lisa A. Cassis1,2

1Cardiovascular Research Center, Gill Heart Institute and 2Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, Kentucky

Submitted 9 June 2006 ; accepted in final form 4 January 2007

In addition to the well-defined contribution of the liver, adipose tissue has been recognized as an important source of angiotensinogen (AGT). The purpose of this study was to define the angiotensin II (ANG II) receptors involved in regulation of adipose AGT and the relationship of this control to systemic AGT and/or angiotensin peptide concentrations. In LDL receptor-deficient (LDLR–/–) male mice, adipose mRNA abundance of AGT was 68% of that in liver, and adipose mRNA abundance of the angiotensin type 1a (AT1a) receptor (AT1aR) was 38% of that in liver, whereas mRNA abundance of the angiotensin type 2 (AT2) receptor (AT2R) was 57% greater in adipose tissue than in liver. AGT and angiotensin peptide concentrations were decreased in plasma of AT1aR-deficient (AT1aR–/–) mice and were paralleled by reductions in AGT expression in liver. In contrast, adipose AGT mRNA abundance was unaltered in AT1aR–/– mice. AT2R–/– mice exhibited elevated plasma angiotensin peptide concentrations and marked elevations in adipose AGT and AT1aR mRNA abundance. Increases in adipose AGT mRNA abundance in AT2R–/– mice were abolished by losartan. In contrast, liver AGT and AT1aR mRNA abundance were unaltered in AT2R–/– mice. Infusion of ANG II for 28 days into LDLR–/– mice markedly increased adipose AGT and AT1aR mRNA but did not alter liver AGT and AT1aR mRNA. These results demonstrate that differential mRNA abundance of AT1a/AT2 receptors in adipose tissue vs. liver contributes to tissue-specific ANG II-mediated regulation of AGT. Chronic infusion of ANG II robustly stimulated AT1aR and AGT mRNA abundance in adipose tissue, suggesting that adipose tissue serves as a primary contributor to the activated systemic renin-angiotensin system.

angiotensin II receptors; renin-angiotensin system; cardiovascular disease; obesity-related disorders; metabolic syndrome



Address for reprint requests and other correspondence: L. A. Cassis, Graduate Center for Nutritional Sciences, Rm. 521b, Wethington Bldg., 900 S. Limestone, Univ. of Kentucky, Lexington, KY 4053-0200 (e-mail: lcassis{at}uky.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Gupte, C. M. Boustany-Kari, K. Bharadwaj, S. Police, S. Thatcher, M. C. Gong, V. L. English, and L. A. Cassis
ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R781 - R788.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.